Guangzhou Restaurant Group Company Limited (603043.SS)
CNY 17.1
(-0.52%)
CNY 17.1
(-0.52%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.67 Billion CNY | 15.44% |
| 2022 | 2.31 Billion CNY | 41.33% |
| 2021 | 1.63 Billion CNY | 28.08% |
| 2020 | 1.27 Billion CNY | 77.48% |
| 2019 | 720.38 Million CNY | 41.71% |
| 2018 | 508.36 Million CNY | 23.68% |
| 2017 | 411.04 Million CNY | 8.91% |
| 2016 | 377.4 Million CNY | 24.24% |
| 2015 | 303.77 Million CNY | 11.49% |
| 2014 | 272.46 Million CNY | -9.46% |
| 2013 | 300.92 Million CNY | 13.07% |
| 2012 | 266.14 Million CNY | 2.87% |
| 2011 | 258.72 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | -489.22 Million CNY | 40.87% |
| 2024 Q2 | 2.47 Billion CNY | 2.76% |
| 2024 Q1 | 2.4 Billion CNY | -10.0% |
| 2023 Q4 | 2.67 Billion CNY | -23.38% |
| 2023 FY | 2.67 Billion CNY | 15.44% |
| 2023 Q1 | 2.37 Billion CNY | 2.69% |
| 2023 Q3 | 3.48 Billion CNY | 34.55% |
| 2023 Q2 | 2.59 Billion CNY | 9.05% |
| 2022 FY | 2.31 Billion CNY | 41.33% |
| 2022 Q1 | 1.48 Billion CNY | -9.23% |
| 2022 Q3 | 2.42 Billion CNY | 46.46% |
| 2022 Q4 | 2.31 Billion CNY | -4.43% |
| 2022 Q2 | 1.65 Billion CNY | 11.23% |
| 2021 Q1 | 1.3 Billion CNY | 2.41% |
| 2021 Q2 | 1.39 Billion CNY | 6.34% |
| 2021 Q3 | 2.23 Billion CNY | 60.49% |
| 2021 FY | 1.63 Billion CNY | 28.08% |
| 2021 Q4 | 1.63 Billion CNY | -26.72% |
| 2020 FY | 1.27 Billion CNY | 77.48% |
| 2020 Q3 | 1.52 Billion CNY | 121.26% |
| 2020 Q2 | 689.34 Million CNY | 2.71% |
| 2020 Q1 | 671.13 Million CNY | -6.84% |
| 2020 Q4 | 1.27 Billion CNY | -16.17% |
| 2019 Q3 | 1.11 Billion CNY | 51.57% |
| 2019 FY | 720.38 Million CNY | 41.71% |
| 2019 Q4 | 720.38 Million CNY | -35.38% |
| 2019 Q2 | 735.49 Million CNY | 79.7% |
| 2019 Q1 | 409.29 Million CNY | -19.49% |
| 2018 Q1 | 332.91 Million CNY | -19.01% |
| 2018 FY | 508.36 Million CNY | 23.68% |
| 2018 Q4 | 508.36 Million CNY | -49.68% |
| 2018 Q3 | 1.01 Billion CNY | 82.41% |
| 2018 Q2 | 553.84 Million CNY | 66.36% |
| 2017 FY | 411.04 Million CNY | 8.91% |
| 2017 Q3 | 940.8 Million CNY | 112.02% |
| 2017 Q4 | 411.04 Million CNY | -56.31% |
| 2017 Q2 | 443.72 Million CNY | 57.67% |
| 2017 Q1 | 281.42 Million CNY | -25.43% |
| 2016 Q4 | 377.4 Million CNY | 0.0% |
| 2016 FY | 377.4 Million CNY | 24.24% |
| 2015 FY | 303.77 Million CNY | 11.49% |
| 2014 Q1 | 422.9 Million CNY | 0.0% |
| 2014 Q2 | 423.17 Million CNY | 0.06% |
| 2014 Q4 | 272.46 Million CNY | 0.38% |
| 2014 FY | 272.46 Million CNY | -9.46% |
| 2014 Q3 | 271.42 Million CNY | -35.86% |
| 2013 FY | 300.92 Million CNY | 13.07% |
| 2012 FY | 266.14 Million CNY | 2.87% |
| 2011 FY | 258.72 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd | 355.39 Million CNY | -651.752% |